TD Private Client Wealth LLC Boosts Position in Bath & Body Works, Inc. (NYSE:BBWI)

TD Private Client Wealth LLC grew its position in Bath & Body Works, Inc. (NYSE:BBWI) by 34.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,290 shares of the company’s stock after buying an additional 593 shares during the quarter. TD Private Client Wealth LLC’s holdings in Bath & Body Works were worth $89,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Golden State Wealth Management LLC acquired a new stake in Bath & Body Works in the 4th quarter valued at about $26,000. SRS Capital Advisors Inc. grew its position in shares of Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after purchasing an additional 329 shares during the last quarter. True Wealth Design LLC increased its stake in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares in the last quarter. UMB Bank n.a. raised its position in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its stake in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Trading Down 0.7 %

Shares of Bath & Body Works stock opened at $32.19 on Wednesday. The business’s fifty day moving average price is $35.52 and its 200 day moving average price is $34.03. Bath & Body Works, Inc. has a twelve month low of $26.21 and a twelve month high of $52.99. The stock has a market capitalization of $6.90 billion, a P/E ratio of 7.85, a PEG ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. The business had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works declared that its Board of Directors has approved a share buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.49%. Bath & Body Works’s dividend payout ratio (DPR) is 21.98%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on BBWI shares. Telsey Advisory Group reissued an “outperform” rating and set a $43.00 price target on shares of Bath & Body Works in a research report on Thursday, February 27th. Raymond James reissued an “outperform” rating and issued a $46.00 target price (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and raised their price target for the stock from $40.00 to $48.00 in a research note on Friday, February 28th. TD Cowen boosted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Finally, Cowen reissued a “buy” rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average price target of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.